Prosthetic Socket Design for Amputees
Trial Summary
What is the purpose of this trial?
This study will investigate the effects of specific standardized modifications to trans-femoral prosthetic sockets in a randomized within-subject design. This is in preparation for a subsequently planned clinical trial to validate the findings by implementing them into a fitting method for individual sockets.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Trans-femoral prosthetic socket?
The research suggests that both the quadrilateral and ischial containment socket designs have been used successfully for many years, with each having a legitimate place in treating patients with transfemoral amputations. Additionally, the development of the subischial socket aims to improve comfort and quality of life for users, indicating ongoing efforts to enhance socket design.12345
Is the prosthetic socket design for amputees generally safe for humans?
The research indicates that different prosthetic socket designs, like the quadrilateral and ischial containment sockets, have been used for many years and are generally considered safe for humans. They have more similarities than differences, and both have a legitimate place in treating patients with transfemoral amputations.13467
How is the Trans-femoral prosthetic socket treatment unique for amputees?
The Trans-femoral prosthetic socket treatment is unique because it includes various designs like the Direct Socket, which is shaped and laminated directly on the residual limb in a single visit, and the Sub-Ischial Socket, which has lower trim lines for improved comfort and function. These innovations aim to address common issues like discomfort and restricted function associated with traditional socket designs.12348
Research Team
William Anderst, PhD
Principal Investigator
University of Pittsburgh
Eligibility Criteria
This trial is for individuals aged 18-80 who use a transfemoral prosthesis, can walk unassisted on a treadmill, and weigh less than 125 kg. It's not suitable for those with high radiation exposure, pregnant women, or anyone clinically diagnosed with osteoporosis.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo testing with unmodified and 8 modified socket designs in a randomized order
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Trans-femoral prosthetic socket
Trans-femoral prosthetic socket is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
- Transfemoral amputations
- Transfemoral amputations
- Transfemoral amputations
- Transfemoral amputations
- Transfemoral amputations
- Transfemoral amputations
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
United States Department of Defense
Collaborator